Survival of patients with de novo myelodysplastic syndromes (MDS) and del(5q)

被引：0
|
作者：
Gritsaev, S. [1 ]
Martinkevitch, I. [1 ]
Petrova, E. [1 ]
Kostroma, I. [1 ]
Ivanova, M. [1 ]
Sergeev, A. [1 ]
Tiranova, S. [1 ]
Potichonova, N. [1 ]
机构：
[1] Inst Hematol & Transfusiol, St Petersburg, Russia
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70192-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-144
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [1] SURVIVAL OF PATIENTS WITH DE NOVO MYELODYSPLASTIC SYNDROME AND del(5q)
    Gritsaev, S. V.
    Martynkevich, I. S.
    Petrova, E. V.
    Martynenko, L. S.
    Kostroma, I. I.
    Ivanova, M. P.
    Tsybakova, N. Yu.
    Kozlovskaya, M. A.
    Sergeyev, A. N.
    Tiranova, S. A.
    Potikhonova, N. A.
    Abdulkadyrov, K. M.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (01): : 3 - 9
  • [2] Variability in the extent of del(5q) in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Vesela, Denisa
    Belickova, Monika
    Vesela, Jitka
    Izakova, Silvia
    Sarova, Iveta
    Lizcova, Libuse
    Ransdorfova, Sarka
    Pavlistova, Lenka
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    Michalova, Kyra
    MOLECULAR CYTOGENETICS, 2019, 12
  • [3] Conditional Survival in Patients with Del(5q) Myelodysplastic Syndromes Treated with Lenalidomide
    Gerds, Aaron T.
    List, Alan F.
    Giagounidis, Aristoteles
    Hellstrom-Lindberg, Eva
    Li, Jack Shiansong
    Swern, Arlene S.
    Sugrue, Mary M.
    Fenaux, Pierre
    Sekeres, Mikkael A.
    BLOOD, 2015, 126 (23)
  • [4] CYTOGENETIC CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES (MDS) WITH ISOLATED DEL(5Q)
    Zemanova, Z.
    Michalova, K.
    Brezinova, J.
    Svobodova, K.
    Lhotska, H.
    Sarova, I.
    Lizcova, L.
    Izakova, S.
    Ransdorfova, S.
    Pavlistova, L.
    Berkova, A.
    Skipalova, K.
    Belickova, M.
    Siskova, M.
    Neuwirtova, R.
    Cermak, J.
    Stopka, T.
    Jonasova, A.
    LEUKEMIA RESEARCH, 2017, 55 : S56 - S57
  • [5] Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
    Giagounidis, Aristoteles A. N.
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 312 - 322
  • [6] DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE
    Gerds, A. T.
    List, A. F.
    Giagounidis, A.
    Hellstrom-Lindberg, E.
    Li, J. Shiansong
    Swern, A. S.
    Sugrue, M. M.
    Fenaux, P.
    Sekeres, M. A.
    LEUKEMIA RESEARCH, 2015, 39 : S109 - S109
  • [7] Variability in the extent of del(5q) and its clinical implication in myelodysplastic syndromes (MDS).
    Zemanova, Zuzana
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Izakova, Silvia
    Sarova, Iveta
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Variability in the size of del(5q) and its clinical implication in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Sejgunovova, Nikola
    Svobodova, Karla
    Lhotska, Halka
    Vidlakova, Denisa
    Aghova, Tatiana
    Lizcova, Libuse
    Izakova, Silvia
    Mendlikova, Iveta
    Ransdorfova, Sarka
    Hodanova, Lucie
    Pavlistova, Lenka
    Belickova, Monika
    Brezinova, Jana
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 559 - 560
  • [9] Atypical deletion of 5q in myelodysplastic syndromes (MDS)
    Zemanova, Z.
    Brezinova, J.
    Svobodova, K.
    Lhotska, H.
    Izakova, S.
    Lizcova, L.
    Vesela, D.
    Ransdorfova, S.
    Mendlikova, I.
    Michalova, K.
    Cermak, J.
    Jonasova, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 510 - 510
  • [10] Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
    Talati, Chetasi
    Sallman, David
    List, Alan
    SEMINARS IN HEMATOLOGY, 2017, 54 (03) : 159 - 166
12345